Surveillance imaging for high-grade childhood brain tumors: What to do 10 years after completion of treatment?

Pediatric Blood & Cancer
Maria Otth, Katrin Scheinemann

Abstract

Brain tumors are the second most common childhood cancer. Treatment protocols for high-grade pediatric brain tumors recommend regular follow-up imaging for up to 10 years. We review maximal time to recurrence and minimal time to radiologically detectable long-term sequelae such as secondary malignancies, vascular complications, and white matter disease. No tumors recurred after the 10-year point, but radiological long-term sequelae grew more common as the treatment completion date receded. We do not recommend regular imaging more than 10 years after treatment has ended, unless there are clinical symptoms.

References

Feb 28, 2002·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·U DietrichD Stolke
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joanne M HildenJaclyn A Biegel
May 25, 2005·Skull Base : Official Journal of North American Skull Base Society ... [et Al.]·Imad KanaanHuda Kanaan
Jul 20, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stewart J KellieUNKNOWN Australian and New Zealand Children's Haematology Oncology Group
Jun 15, 2007·Journal of Neurosurgery·Sasha BurnRichard Hayward
Sep 19, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Jae-Whan LeeJoong-Uhn Choi
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan N ChiMark W Kieran
Mar 3, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Katja von HoffStefan Rutkowski
Jun 19, 2009·Journal of the National Cancer Institute·Gregory T ArmstrongRoger J Packer
Jan 30, 2010·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Gregory T Armstrong
Jul 22, 2010·International Journal of Radiation Oncology, Biology, Physics·Maura MassiminoMaria Luisa Garrè
Aug 10, 2010·Journal of Neuro-oncology·Johannes E WolffChristoph Kramm
Mar 4, 2011·Pediatric Blood & Cancer·Rajkumar VenkatramaniJonathan L Finlay
Oct 26, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Lafay-CousinA Huang
Feb 3, 2012·Journal of Neurosurgery. Pediatrics·Wajd N Al-HolouCormac O Maher
Apr 2, 2013·Journal of Neurosurgery. Pediatrics·Tene A CageKurtis I Auguste
Aug 8, 2013·Journal of Neuro-oncology·Sébastien PerreaultSonia Partap
Jan 10, 2014·Journal of Neuro-oncology·Sébastien PerreaultSonia Partap
Sep 13, 2014·Pediatric Blood & Cancer·Leeat GranekMaru Barrera
Aug 4, 2015·Pediatric Hematology and Oncology·Michael KarremannChristof M Kramm
Oct 17, 2015·Journal of Neurosurgery. Pediatrics·Bradley A GrossEdward R Smith
Feb 26, 2016·Journal of Pediatric Hematology/oncology·Carl KoschmannSarah E S Leary
Oct 19, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ki Woong SungHyung Jin Shin
May 27, 2016·Cancer Medicine·Kerstin BartelheimMichael Christoph Frühwald
Jul 18, 2016·Journal of Neuro-oncology·Magnus SabelUNKNOWN SIOP-E Brain Tumour Group
Nov 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·André O von BuerenStefan Rutkowski
Jan 17, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Fatima TensaoutiUNKNOWN radiotherapy committee of the French Society for Childhood Cancer (SFCE)
Apr 11, 2017·Clinical Imaging·Mika Shapira RootmanHelen Toledano

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.